EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections

Nikki N Tran, Taylor Morrisette, Sarah C J Jorgensen iD, José M Orench-Benvenutti, Razieh Kebriaei iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023-08 · 43 (8) · 816-832

DOI: 10.1002/phar.2806 ↗

At a glance

Übersichtsarbeit in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, published online on 2023-05-14. Written by Nikki N Tran and 4 co-authors. Institution: Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, US…. Major MEDLINE topics: Staphylococcal Infections, Community-Acquired Infections, Methicillin-Resistant Staphylococcus aureus. Cited 74 times so far (Crossref); 177 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections and contributes to significant increase in morbidity and mortality especially when associated with medical devices and in biofilm form. Biofilm structure provides a pathway for the enrichment of resistant and persistent phenotypes of S. aureus leading to relapse and recurrence of infection. Minimal diffusion of antibiotics inside biofilm structure leads to heterogeneity and distinct physiological activity. Additionally, horizontal gene transfer between cells in proximity adds to the challenges associated with eradication of biofilms. This narrative review focuses on biofilm‐associated infections caused by S. aureus , the impact of environmental conditions on biofilm formation, interactions inside biofilm communities, and the clinical challenges that they present. Conclusively, potential solutions, novel treatment strategies, combination therapies, and reported alternatives are discussed.

Subjects

MeSH terms (MEDLINE)

Staphylococcal InfectionsCommunity-Acquired InfectionsMethicillin-Resistant Staphylococcus aureusHumansStaphylococcus aureusBiofilmsAnti-Bacterial AgentsMicrobial Sensitivity Tests

Author keywords

Staphylococcus aureusMRSAbiofilm

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
  • Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.
  • Department of Pharmacy Services, Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, USA.
  • Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • P3 Research Laboratory, Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

ORCID profiles: Sarah C J Jorgensen, Razieh Kebriaei

Cite

APA

Tran, N. N., Morrisette, T., Jorgensen, S. C. J., Orench-Benvenutti, J. M., & Kebriaei, R. (2023). Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(8), 816-832. https://doi.org/10.1002/phar.2806

Vancouver

Tran NN, Morrisette T, Jorgensen SCJ, Orench-Benvenutti JM, Kebriaei R. Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023;43(8):816-832. doi:10.1002/phar.2806

BibTeX
@article{Tran2023,
  author = {Tran, Nikki N and Morrisette, Taylor and Jorgensen, Sarah C J and Orench-Benvenutti, José M and Kebriaei, Razieh},
  title = {Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2023},
  volume = {43},
  number = {8},
  pages = {816--832},
  doi = {10.1002/phar.2806}
}
Start for free →